(1) The general assembly declares that the purpose of this part 15 is to:
(a) Prohibit a pharmacy benefit manager or carrier from imposing fees, charge backs, or other adjustments on covered entities or contract pharmacies based on their participation in the 340B drug pricing program;
(b) Prohibit a pharmacy benefit manager or carrier from requiring a claim for a drug to include a modifier to indicate that the drug is a 340B drug unless the claim is for payment, directly or indirectly, by the medicaid program; and
(c) Provide for powers and duties of the commissioner and the division.
Source: L. 2022: Entire part added, (HB 22-1122), ch. 312, p. 2230, � 1, effective August 10.